Metachromatische Leukodystrophie
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/3/9/7/6/000008_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/3/9/7/7/000012_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/3/9/7/8/000013_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/3/9/7/9/000017_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/3/9/8/0/000015_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/0/0/8/2/8/13023_2019_1113_Fig3_HTML_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/0/metachromaticleukodystrophy01mdgaitdisturbanceincreasedbilateralsymmetricalt2signalinwhitemattermrt2flair5yo_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/0/5/9/9/6/6c3107133c68bc956da752779381e2_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/1/846b6683fd923e413ad65c1f9bcc56f3b5dae9e0fef9d1bf5097d0372cd6f001_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/2/1fbb446e4c809a92afa283c6cde6d2_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/3/4ea37afd1bcbb8eaad1dfea08c9753_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/4/a0b508d41924d5a4f04df45ed8bfa52374fc0a3722ab80880abe76e369a25fb8_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/5/0750b3a8ed062c439f22c487777752_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/5/3/4/6/16._big_gallery_thumb.jpg)
Metachromatic leukodystrophy (MLD) is the most common hereditary (autosomal recessive) leukodystrophy and is one of the lysosomal storage disorders. It has characteristic imaging features including peri-atrial and to a lesser extent frontal horns leukodystrophy as well as periventricular perivenular sparing results in "tigroid pattern" on fluid-sensitive MRI sequences.
Epidemiology
It has an estimated prevalence of ~1:100,000 and typically manifests between 12 to 18 months of age. The disease can sometimes be classified according to the time of onset:
- late infantile: most common ~65% (range 50-80%)
- juvenile (onset between 3-10 years)
- adult (after age 16)
Clinical presentation
Clinical presentation depends on the age of onset.
- late infantile form
- gait abnormality, muscle rigidity, loss of vision, impaired swallowing, convulsions, dementia
- juvenile form
- impaired school performance; similar features as in late infantile form but slower progression
- adult form
- adult presentation accounts for 20% of all cases
- neuropsychiatric disorders
- gradual cognitive decline and dementia
- motor symptoms are a late feature
- often protracted course over 10 years
Because sulfatide accumulates also in the wall of the gallbladder, cholecystitis is a recognized complication .
Pathology
Metachromatic leukodystrophy is classified as a dysmyelinating disease and carries an autosomal recessive inheritance. It arises from a deficiency of the enzyme arylsulfatase A as a result of a mutation in the arylsulfatase A (ARSA) gene located on chromosome 22q13. This results in the accumulation of 3-O-sulfogalactosylceramide (sulfatide) in various organs including the central nervous system (Schwann cells, oligodendrocytes, and some neurons) impairing myelination and function .
Metachromatic refers to the histologic staining characteristic caused by abnormal accumulations of sulfatides in white matter .
Markers
- serum/urine arylsulfatase A levels: reduced
Radiographic features
MRI
Characterized by bilateral symmetrical confluent areas of periventricular deep white matter signal change, in particular around the atria and frontal horns with sparing of subcortical U fibers leading to a "butterfly pattern". Progression can lead to cortical and subcortical atrophy .
Signal characteristics
- T1: affected areas are low signal
- T1 C+ (Gd)
- no enhancement is characteristic
- however, some cases may show a linear punctate enhancement pattern within lesions
- multiple cranial nerve enhancement has been reported
- T2:
- affected areas are high signal and may show a "tigroid pattern" on axial plane or "leopard pattern" on sagittal plane representing sparing along the venules
- subcortical U-fibers are usually spared
- MR spectroscopy: (of affected white matter)
- reduced N-acetyl aspartate (NAA)
- increased myoinositol
- increased lactate
Differential diagnosis
In addition to many of the other leukodystrophies, a tigroid pattern of involvement may also be seen in:
Siehe auch:
und weiter:
![Click für weniger anzeigen](/sites/all/modules/pacs/tools/imgs/collapse_up.png)
![](/sites/all/modules/pacs/tools/imgs/Iris_color_40.png)